0001103021-21-000006.txt : 20210129 0001103021-21-000006.hdr.sgml : 20210129 20210129190521 ACCESSION NUMBER: 0001103021-21-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210127 FILED AS OF DATE: 20210129 DATE AS OF CHANGE: 20210129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Thomas B CENTRAL INDEX KEY: 0001748462 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 21573519 MAIL ADDRESS: STREET 1: BIODELIVERY SCIENCES INTERNATIONAL, INC. STREET 2: 4131 PARKLAKE AVE SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 4 1 wf-form4_161196510268074.xml FORM 4 X0306 4 2021-01-27 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001748462 Smith Thomas B C/O BIODELIVERY SCIENCES INTL, INC., 4131 PARKLAKE AVE. SUITE 225 RALEIGH NC 27612 0 1 0 0 Chief Medical Officer Stock Options (right to buy) 3.84 2021-01-27 4 A 0 287194 0 A 2031-01-26 Common Stock 287194.0 287194 D Restricted Stock Units 0.0 2021-01-27 4 A 0 52083 0 A 2024-01-27 Common Stock 52083.0 52083 D The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2021. The stock options were issued to the Reporting Person on January 27, 2021, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2022; (ii) January 27, 2023; and (iii) January 27, 2024. The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2021, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2022; (ii) January 27, 2023; and (iii) January 27, 2024. Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. /s/ Thomas Smith, MD. 2021-01-29